atorvastatin has been researched along with Weight Gain in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bass, JY; Caravella, JA; Chen, L; Creech, KL; Deaton, DN; Madauss, KP; Marr, HB; McFadyen, RB; Miller, AB; Mills, WY; Navas, F; Parks, DJ; Smalley, TL; Spearing, PK; Todd, D; Williams, SP; Wisely, GB | 1 |
He, X; Liang, L; Liu, S; Peng, C; Xiao, C; Zhang, G; Zhao, S | 1 |
Augustin, S; Barberá, A; Bravo, M; Estrella, F; Genescà , J; Gil, M; Hide, D; Martell, M; Raurell, I; Salcedo, MT | 1 |
Bangalore, S; DeMicco, DA; Fayyad, R; Laskey, R; Messerli, FH; Waters, DD | 1 |
Das, DK; Das, N; Dey, S; Kesh, SB; Khan, A; Manna, K; Sikder, K | 1 |
Holmberg, B; Stegmayr, BG | 1 |
Anthony, FW; Curzen, NP; Hanson, MA; Hopkins, LA; Kelsall, CJ; Torrens, C | 1 |
Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN | 1 |
Ghante, MH; Ghule, BV; Saoji, AN; Yeole, PG | 1 |
Ananthi, S; Chandronitha, C; Gayathri, V; Sangeetha, MK; Vasanthi, HR | 1 |
1 trial(s) available for atorvastatin and Weight Gain
Article | Year |
---|---|
Body-Weight Fluctuations and Outcomes in Coronary Disease.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Weight Gain; Weight Loss | 2017 |
9 other study(ies) available for atorvastatin and Weight Gain
Article | Year |
---|---|
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.
Topics: Animals; Binding Sites; Blood Glucose; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Dogs; Fluorescence Resonance Energy Transfer; Humans; Isoxazoles; Ligands; Mice; Molecular Conformation; Naphthalenes; Protein Structure, Tertiary; Quinolines; Rats; Receptors, Cytoplasmic and Nuclear; Weight Gain | 2011 |
Probiotic strains improve high-fat diet-induced hypercholesterolemia through modulating gut microbiota in ways different from atorvastatin.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bacteria; Cricetinae; Cytokines; Diet, High-Fat; Dysbiosis; Feces; Gastrointestinal Microbiome; Glucose; Hypercholesterolemia; Lactobacillus plantarum; Male; Mesocricetus; Pediococcus; Pediococcus acidilactici; Pediococcus pentosaceus; Probiotics; Weight Gain | 2019 |
Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH.
Topics: Alanine Transaminase; Animals; Atorvastatin; Biomarkers; Collagen; Disease Models, Animal; Drug Synergism; Endothelial Cells; Endothelin-1; Enzyme Activation; Hemodynamics; Hepatic Stellate Cells; Insulin Resistance; Liver; Liver Cirrhosis; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Phenylpropionates; Pyridazines; Weight Gain | 2021 |
Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice.
Topics: Animals; Antioxidants; Atorvastatin; Coumaric Acids; Diet, High-Fat; Drug Therapy, Combination; Free Radical Scavengers; Hepatocytes; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Interleukin-6; Lipid Peroxidation; Liver; Male; Mice; NF-kappa B; Oxidative Stress; Pyrroles; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain.
Topics: Adult; Aged; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Female; Heptanoic Acids; Humans; Male; Middle Aged; Prospective Studies; Pyrroles; Regression Analysis; Renal Dialysis; Weight Gain | 2009 |
Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
Topics: Animals; Atorvastatin; Cholesterol; Disease Models, Animal; Endothelium, Vascular; Female; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Protein-Energy Malnutrition; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Vasculitis; Vasoconstriction; Weight Gain | 2009 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glutathione Peroxidase; Heptanoic Acids; Hyperglycemia; Hyperlipidemias; Insulin; Ketanserin; Lipid Peroxidation; Lipogenesis; Liver; Malondialdehyde; Mice; Mice, Inbred C57BL; Piperazines; PPAR gamma; Prazosin; Propranolol; Pyrroles; Superoxide Dismutase; Weight Gain | 2009 |
Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria Stand. fruit in hyperlipidemic rats.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bile Acids and Salts; Cholesterol; Cucurbitaceae; Dietary Fats; Disease Models, Animal; Feces; Fruit; Heptanoic Acids; Hyperlipidemias; Hypolipidemic Agents; Male; Phytotherapy; Plant Extracts; Pyrroles; Rats; Rats, Wistar; Triglycerides; Weight Gain | 2009 |
Hypolipidemic potential of flowers of Nerium oleander in high fat diet-fed Sprague Dawley rats.
Topics: Animals; Atorvastatin; Dietary Fats; Flowers; Heptanoic Acids; Hypolipidemic Agents; Lipoproteins; Nerium; Plant Extracts; Pyrroles; Rats; Rats, Sprague-Dawley; Weight Gain | 2011 |